Nuvation Bio Inc
NYSE:NUVB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Nuvation Bio Inc (NUVB) under the Base Case is USD per share.
Compared with the current market price of 3.99 USD, the stock appears .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Nuvation Bio Does
Nuvation Bio is a cancer drug developer. It does not run hospitals or sell medical equipment; instead, it works in labs and clinical trials to build new medicines for hard-to-treat cancers. Its main job is to take drug candidates through testing and toward regulatory approval.
- Headquarters
- United States of America US
- Employees
- 298
- IPO date
- Jul 1, 2020
Earnings Waterfall
Nuvation Bio Inc
What is the Intrinsic Value of one NUVB stock?
The intrinsic value for Nuvation Bio Inc (NUVB) under the Base Case is USD.
Is NUVB stock undervalued or overvalued?
Compared with the current market price of 3.99 USD, the stock appears .
